Confounding roles for type I interferons during bacterial and viral pathogenesis
Open Access
- 24 October 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 25 (12) , 663-669
Abstract
Although type I interferons (IFN-I) were initially defined as potent antiviral agents, they can also cause decreased host resistance to some bacterial and viral infections. The many antiviral functions of the IFN-I include direct suppression of viral replication and activation of the immune response against viruses. In addition to their antiviral effects, IFN-I are also protective against several extracellular bacterial infections, in part, by promoting the induction of TNF-α and nitric oxide. In contrast, there is a negative effect of IFN-I on host resistance during chronic infection with lymphocytic choriomeningitis virus (LCMV) and acute infections with intracellular bacteria. In the case of LCMV, chronic IFN-I signaling induces adaptive immune system suppression. Blockade of IFN-I signaling removes the suppression and allows CD4 T-cell- and IFN-γ-mediated resolution of the infection. During acute intracellular bacterial infection, IFN-I suppress innate immunity by at least two defined mechanisms. During Francisella infection, IFN-I prevent IL-17 upregulation on γδ T cells and neutrophil recruitment. Following Listeria infection, IFN-I promote the cell death of macrophages and lymphocytes, which leads to innate immune suppression. These divergent findings for the role of IFN-I on pathogen control emphasize the complexity of the interferons system and force more mechanistic evaluation of its role in pathogenesis. This review evaluates IFN-I during infection with an emphasis on work carried out IFN-I-receptor-deficient mice.Keywords
This publication has 76 references indexed in Scilit:
- Type I Interferon Induction during Influenza Virus Infection Increases Susceptibility to Secondary Streptococcus pneumoniae Infection by Negative Regulation of γδ T CellsJournal of Virology, 2012
- The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune responseNature Immunology, 2012
- Systematic identification of type I and type II interferon-induced antiviral factorsProceedings of the National Academy of Sciences, 2012
- Viral Infection Augments Nod1/2 Signaling to Potentiate Lethality Associated with Secondary Bacterial InfectionsCell Host & Microbe, 2011
- Regulation of effector and memory T-cell functions by type I interferonImmunology, 2011
- Type I interferon: friend or foe?Journal of Experimental Medicine, 2010
- c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon ResponseScience, 2010
- Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral InfectionsJournal of Virology, 2010
- Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirusJournal of Experimental Medicine, 2007
- HIV-1 immunopathogenesis: How good interferon turns badClinical Immunology, 2007